Skip to content

SOLIGENIX, INC.: 10-Q filed 2025-11-07

What SOLIGENIX, INC. reported in its quarterly report filed 2025-11-07 (fiscal Q3 2025): 37 published measures, 105 facts as tagged in accession 0001104659-25-108475.

This filing

Form
10-Q (quarterly report)
Filed
2025-11-07
Fiscal period
fiscal Q3 2025
Accession
0001104659-25-108475 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SOLIGENIX, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-09-3011,293,917USD
At 2024-12-318,966,483USD
At 2024-09-3010,476,979USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-09-303,695,941USD
At 2024-12-314,848,412USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-09-307,597,976USD
At 2025-06-301,828,951USD
At 2024-12-314,118,071USD
At 2024-09-305,935,188USD
At 2024-06-303,464,776USD
At 2023-12-312,522,422USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-2,530,947USD92
2025-01-01 to 2025-09-30-8,184,191USD273
2024-07-01 to 2024-09-30-1,719,381USD92
2024-01-01 to 2024-09-30-5,279,210USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-7,521,449USD273
2024-01-01 to 2024-09-30-6,170,761USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2025-01-01 to 2025-09-303,921USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2024-01-01 to 2024-09-30119,371USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-09-3010,231,191USD273
2024-01-01 to 2024-09-307,519,211USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-3,921USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-09-30-242,154,943USD
At 2024-12-31-233,970,752USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-07-01 to 2025-09-304,329,649shares92
2025-01-01 to 2025-09-303,557,339shares273
2024-07-01 to 2024-09-302,203,929shares92
2024-01-01 to 2024-09-301,376,568shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-07-01 to 2025-09-304,329,649shares92
2025-01-01 to 2025-09-303,557,339shares273
2024-07-01 to 2024-09-302,203,929shares92
2024-01-01 to 2024-09-301,376,568shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-0.58USD/shares92
2025-01-01 to 2025-09-30-2.3USD/shares273
2024-07-01 to 2024-09-30-0.78USD/shares92
2024-01-01 to 2024-09-30-3.84USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-0.58USD/shares92
2025-01-01 to 2025-09-30-2.3USD/shares273
2024-07-01 to 2024-09-30-0.78USD/shares92
2024-01-01 to 2024-09-30-3.84USD/shares274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-09-307,812USD
At 2024-12-316,113USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2025-01-01 to 2025-09-30267,458USD273
2024-01-01 to 2024-09-30174,268USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-2,580,483USD92
2025-01-01 to 2025-09-30-8,370,870USD273
2024-07-01 to 2024-09-30-1,865,236USD92
2024-01-01 to 2024-09-30-5,727,002USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-09-3010,880,913USD
At 2024-12-318,828,630USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-09-303,422,021USD
At 2024-12-314,848,412USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2025-09-301,206,796USD
At 2024-12-31667,896USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-07-01 to 2025-09-302,580,483USD92
2025-01-01 to 2025-09-308,370,870USD273
2024-07-01 to 2024-09-301,865,236USD92
2024-01-01 to 2024-09-305,727,002USD274

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2024-01-01 to 2024-09-30119,371USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-07-01 to 2025-09-301,583,879USD92
2025-01-01 to 2025-09-305,202,573USD273
2024-07-01 to 2024-09-30968,689USD92
2024-01-01 to 2024-09-302,564,887USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-09-309,861,130shares
At 2024-12-312,514,499shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-09-3010,525,335USD
At 2024-12-317,819,514USD
At 2024-09-309,840,177USD
At 2023-12-318,446,158USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-09-30249,697,269USD
At 2024-12-31238,040,520USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2025-09-3045,789USD
At 2024-12-3145,789USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2025-09-30382,415USD
At 2024-12-31108,963USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2025-09-302,031,272USD
At 2024-12-312,359,339USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-2,530,947USD92
2025-01-01 to 2025-09-30-8,184,191USD273
2024-07-01 to 2024-09-30-1,719,381USD92
2024-01-01 to 2024-09-30-5,279,210USD274

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-8,184,191USD273
2024-01-01 to 2024-09-30-5,279,210USD274

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-2,530,947USD92
2025-01-01 to 2025-09-30-8,184,191USD273
2024-07-01 to 2024-09-30-1,709,507USD92
2024-01-01 to 2024-09-30-5,263,980USD274

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-2,530,947USD92
2025-01-01 to 2025-09-30-8,184,191USD273
2024-07-01 to 2024-09-30-1,719,381USD92
2024-01-01 to 2024-09-30-5,279,210USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2025-09-30996,604USD92
2025-01-01 to 2025-09-303,168,297USD273
2024-07-01 to 2024-09-30896,547USD92
2024-01-01 to 2024-09-303,162,115USD274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-2,815USD92
2025-01-01 to 2025-09-30-11,523USD273
2024-07-01 to 2024-09-3067,019USD92
2024-01-01 to 2024-09-30304,189USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-07-01 to 2025-09-3049,536USD92
2025-01-01 to 2025-09-30186,679USD273
2024-07-01 to 2024-09-30145,855USD92
2024-01-01 to 2024-09-30447,792USD274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2025-01-01 to 2025-09-3035,044USD273
2024-01-01 to 2024-09-30183,771USD274

Inspect the source

Entity
SOLIGENIX, INC. / CIK 0000812796
Captured
2026-09-19T15:06:29.331Z
SEC response SHA-256
8629fd5cf775c1125cd5ba8089602df0d09016eba95e768aec70a78328c796d0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000812796.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))